The effect of dopamine and other catecholamines on neuromuscular transmission.
D000818:Animals; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects; D002339:Carotid Arteries; D002415:Cats; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004298:Dopamine / Q000494:pharmacology*; D018492:Dopamine Antagonists; D004336:Drug Antagonism; D004357:Drug Synergism; D004491:Edrophonium / Q000494:pharmacology; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009388:Neostigmine / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects*; D003473:Neuromuscular Nondepolarizing Agents / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology*; D012584:Sciatic Nerve / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects*; D014403:Tubocurarine / Q000494:pharmacology
D018492:Dopamine Antagonists; D003473:Neuromuscular Nondepolarizing Agents; D009388:Neostigmine; D004295:Dihydroxyphenylalanine; D004491:Edrophonium; D004298:Dopamine; D014403:Tubocurarine; D009638:Norepinephrine